ArticleMycobiology2017
Article in Mycobiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 47 citations in OpenAlex.
- Synchronous natural infection of Nile tilapia (Oreochromis niloticus) by drug-resistant Pseudomonas aeruginosa and Saprolegnia parasitica: insights into water quality, phenotypic traits, and genotypic profiles.Veterinary research communications · 2025Article
- Severe Outbreak of Saprolegnia Spp. Infection in Spotted Snakehead (Channa punctata, Bloch 1793): Clinical Assessment, Histopathology, Haemato-Biochemical Indices and Insights Into Therapeutic Effects.Veterinary medicine and science · 2025Article
- Translational Horizons in Computer-Aided Drug Discovery: BridgingAnti-inflammatory & anti-allergy agents in medicinal chemistry · 2025Article
- New Insights into the Morphological Diversity ofJournal of fungi (Basel, Switzerland) · 2023Article
- The hidden world of fish fungal pathogens: molecular identification and phylogenetic analysis in common carp, Cyprinus carpio.Archives of microbiology · 2023Article
- Host-pathogen interaction unveiled by immune, oxidative stress, and cytokine expression analysis to experimental Saprolegnia parasitica infection in Nile tilapia.Scientific reports · 2023Article
- Development of multiplex PCR assay for species-specific detection and identification ofBiotechnology reports (Amsterdam, Netherlands) · 2022Article
- Uncharted Diversity and Ecology ofMycobiology · 2022Article
- Anti-oomycete Activity of Chlorhexidine Gluconate: Molecular Docking andFrontiers in veterinary science · 2022Article
- Article
- Copper/Carbon Core/Shell Nanoparticles: A Potential Material to Control the Fish PathogenFrontiers in veterinary science · 2021Article
- Isolation, molecular identification, and pathological lesions ofVeterinary world · 2020Article
- Molecular insights into the mechanisms of susceptibility of Labeo rohita against oomycete Aphanomyces invadans.Scientific reports · 2020Article
- Anti-saprolegnia potency of some plant extracts againstSaudi journal of biological sciences · 2020Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Saprolegniasis is one of the most devastating oomycete diseases in freshwater fish which is caused by species in the genus
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.